(2R,3S,4S,5S,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5S,6R)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Term ID

CHEBI:153371

Synonyms

alpha-D-manno-hexopyranosyl-(1->3)-[alpha-D-manno-hexopyranosyl-(1->6)]-beta-D-manno-hexopyranose
Man(a1-3)[Man(a1-6)]b-Man
WURCS=2.0/2,3,2/[a1122h-1b_1-5][a1122h-1a_1-5]/1-2-2/a3-b1_a6-c1

Definition

References

GlyGen:G72618IM
GlyTouCan:G72618IM

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3S,4S,5S,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5S,6R)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype where environments contain (2R,3S,4S,5S,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5S,6R)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3S,4S,5S,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5S,6R)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype affecting (2R,3S,4S,5S,6S)-2-(Hydroxymethyl)-6-[[(2R,3R,4S,5S,6R)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Human Disease Model